BioMD:Preclinical trials of ADPT/arterial grafts positive

The ADAPT treated Kangaroo and Bovine pericardial tissue patches and Kangaroo carotid artery grafts were implanted for 200 days and replaced part of the animal's carotid arteries and jugular veins.

BioMD managing director Michael Bennett said the results validated the process as being a leading edge technology that reduced calcification and increased the durability of bioimplants.

"The use of such grafts would replace the need for harvesting of the patients own saphenous or mammary blood vessels that are currently used as replacement grafts," he said.

Further preclinical trials would now be required to evaluate different pre-operative and post-operative treatment regimes, Bennett said.